tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2022 Apr 26;28(6).
doi: 10.3201/eid2806.220427. Online ahead of print.
SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021
Julie R Harris, Daniel Owusu, Kevin O'Laughlin, Adam L Cohen, Amen Ben Hamida, Jaymin C Patel, Molly M Freeman, Thomas Nsibambi, Rebecca Nieves, Barbara J Marston, Samuel Wasike, Jennifer S Galbraith, Amy L Boore, Lisa J Nelson, Sarah Anne J Guagliardo, John D Klena, Ketan Patel, Marek Ma
Abstract
The SARS-CoV-2 Delta variant emerged shortly after COVID-19 vaccines became available in 2021. We describe SARS-CoV-2 breakthrough infections in a highly vaccinated, well-monitored US Embassy community in Kampala, Uganda. Defining breakthrough infection rates in highly vaccinated populations can help determine public health messaging, guidance, and policy globally.
Keywords: COVID-19; SARS; SARS-CoV-2; US Embassy; Uganda; breakthrough; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine; viruses; zoonoses.
. 2022 Apr 26;28(6).
doi: 10.3201/eid2806.220427. Online ahead of print.
SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021
Julie R Harris, Daniel Owusu, Kevin O'Laughlin, Adam L Cohen, Amen Ben Hamida, Jaymin C Patel, Molly M Freeman, Thomas Nsibambi, Rebecca Nieves, Barbara J Marston, Samuel Wasike, Jennifer S Galbraith, Amy L Boore, Lisa J Nelson, Sarah Anne J Guagliardo, John D Klena, Ketan Patel, Marek Ma
- PMID: 35470796
- DOI: 10.3201/eid2806.220427
Abstract
The SARS-CoV-2 Delta variant emerged shortly after COVID-19 vaccines became available in 2021. We describe SARS-CoV-2 breakthrough infections in a highly vaccinated, well-monitored US Embassy community in Kampala, Uganda. Defining breakthrough infection rates in highly vaccinated populations can help determine public health messaging, guidance, and policy globally.
Keywords: COVID-19; SARS; SARS-CoV-2; US Embassy; Uganda; breakthrough; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine; viruses; zoonoses.